亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

71119-23-8MES sodium salt 韻邦工廠

 
 
單價 面議對比
詢價 暫無
發貨 湖南長沙市付款后3天內
品牌 匯百試劑
過期 長期有效
更新 2021-08-13 15:18
 

湖南韻邦生物醫藥有限公司

企業會員第8年
資料未認證
保證金未繳納
詳細說明
中文名稱:2-嗎啉乙磺酸鈉鹽
CAS號:71119-23-8
中文別名: 2-(N-嗎啉)乙磺酸鈉; 美司納; MES鈉鹽
英文名稱:Sodium 2-morpholinoethanesulfonate
英文別名: MES; Sodium 4-morpholin-1-ylethylsulphonate; MESS-Na; 2-Morpholinoethanesulfonic Sodium; SODIUM 2-MORPHOLINOETHANESULFONATE; 4-morpholineethanesulfonic acid sodium salt; 2-MORPHOLINOETHANESULFonIC ACID SODIUM SALT; 2-(N-MORPHOLINO)ETHANESULFonIC ACID, NA; 2-(N-MORPHOLINO)ETHANESULFonIC ACID SODIUM SALT; Methyl ethane sulfonic acid; MES-Na
EINEC:275-203-2
分子式:C6H12NO4S-.NA+
分子量:217.21858
舉報收藏 0評論 0
更多>本企業其它產品
7365-45-9 HEPES 韻邦工廠 匯百試劑 4432-31-9 MES 韻邦生產 匯百試劑 145224-94-8 MES monohydrate 韻邦 7365-44-8 TES 韻邦生產 匯百試劑 7365-82-4 ACES 韻邦生產 匯百試劑 16052-06-5 EPPS 韻邦生產 匯百試劑 5625-37-6 PIPES 韻邦工廠 匯百試劑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |